Showing 1 - 7 results of 7 for search 'Rob Hagendijk', query time: 0.04s Refine Results
  1. 1
    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape

    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape by David Walwyn, Rob Hagendijk

    Published 2012-09-01
    Get full text
    Article
  2. 2
    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape

    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape by David Walwyn, Rob Hagendijk

    Published 2012-09-01
    Get full text
    Article
  3. 3
    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape

    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape by David Walwyn, Rob Hagendijk

    Published 2012-09-01
    Get full text
    Article
  4. 4
    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape

    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape by David Walwyn, Rob Hagendijk

    Published 2012-09-01
    Get full text
    Article
  5. 5
    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape

    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape by David Walwyn, Rob Hagendijk

    Published 2012-09-01
    Get full text
    Article
  6. 6
    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape

    Too many actions, too few priorities: Commentary on the ministerial review of the STI landscape by David Walwyn, Rob Hagendijk

    Published 2012-09-01
    Get full text
    Article
  7. 7
    Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases

    Social pharmaceutical innovation and alternative forms of research, development and deployment for drugs for rare diseases by Conor M. W. Douglas, Fernando Aith, Wouter Boon, Marina de Neiva Borba, Liliana Doganova, Shir Grunebaum, Rob Hagendijk, Larry Lynd, Alexandre Mallard, Faisal Ali Mohamed, Ellen Moors, Claudio Cordovil Oliveira, Florence Paterson, Vanessa Scanga, Julino Soares, Vololona Raberharisoa, Tineke Kleinhout-Vliek

    Published 2022-09-01
    Get full text
    Article

Search Tools: